Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_assertion description "[To determine if ovarian cancer patients would be suitable for MAGE-peptide vaccine-based immunotherapy, the frequency of expression of the MAGE-1-4 genes in ovarian tumours was assessed using reverse transcription polymerase chain reaction (RT-PCR) and product verification with digoxigenin-labelled oligonucleotide probes specific for each MAGE gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_assertion evidence source_evidence_literature NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_assertion SIO_000772 9743307 NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_assertion wasDerivedFrom befree-20150227 NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_assertion wasGeneratedBy ECO_0000203 NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1009700.RAW0G84RscGzu_Ijhpn1cRUdRH3LaoCwnvSK3Vj33NxT4130_provenance.